Dos and Donts IV Therapy is here to help, but its important to make healthy choices when you can
The growth of the GLP-1 market is pushing manufacturers beyond basic sugar reduction toward higher nutritional density. This includes accelerating development of products that combine sugar reduction with metabolic health, and increasing demand for integrated solutions that deliver satiety, glycemic control, and nutritional value simultaneously. Meanwhile, Cargill warns brands and formulators against assuming GLP-1 users will swallow premium pricing automatically
Source: Polaris Market Research Analysis Key Players and Competitive Insights Novo Nordisk maintains a dominant position in the semaglutide market through its exclusive rights to develop, manufacture, and commercialize Ozempic, Wegovy, and Rybelsus
All three medications begin suppressing appetite within the first one to two weeks
Who We Help Fatigue and low energy Brain fog and focus challenges Mood variability and sleep disruption Low libido or sexual dysfunction Weight gain or slowed metabolism We start with targeted labs and a clinical review to see if hormone optimization is a fit for your goals
Session duration can extend to 30-45 minutes as conditioning improves